Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Morand

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Drugs|May 28, 2024
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons LearnedSarah A Jones, Eric F Morand
International Journal of Rheumatic Diseases|December 20, 2014
Vitamin D and systemic lupus erythematosus: continued evolutionKristy S Yap, Eric F Morand
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2008
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosisLeilani L Santos, Eric F Morand
Nature Reviews. Rheumatology|March 11, 2015
Successes, challenges and developments in Australian rheumatologyEric F Morand, Michelle T Leech
Wiener Medizinische Wochenschrift (1946)|February 9, 2006
The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritisLeilani L Santos, Eric F Morand
The Journal of Rheumatology|March 1, 2024
Flare in Systemic Lupus Erythematosus: Lost in Translation?Eric F Morand, Sarah A Jones
The Medical Journal of Australia|February 14, 2002
RheumatologyGeoffrey O Littlejohn, Eric F Morand
The New England Journal of Medicine|April 23, 2020
Anifrolumab in Systemic Lupus Erythematosus. ReplyEric F Morand, Richard A Furie
Trends in Molecular Medicine|July 10, 2025
10 years in lupus - progress, but not enoughEric F Morand, Sarah A Jones
Arthritis and Rheumatism|February 7, 2003
Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritisEric F Morand, Richard Bucala, Michelle Leech
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Drugs|May 28, 2024
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons LearnedSarah A Jones, Eric F Morand
International Journal of Rheumatic Diseases|December 20, 2014
Vitamin D and systemic lupus erythematosus: continued evolutionKristy S Yap, Eric F Morand
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2008
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosisLeilani L Santos, Eric F Morand
Nature Reviews. Rheumatology|March 11, 2015
Successes, challenges and developments in Australian rheumatologyEric F Morand, Michelle T Leech
Wiener Medizinische Wochenschrift (1946)|February 9, 2006
The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritisLeilani L Santos, Eric F Morand
The Journal of Rheumatology|March 1, 2024
Flare in Systemic Lupus Erythematosus: Lost in Translation?Eric F Morand, Sarah A Jones
The Medical Journal of Australia|February 14, 2002
RheumatologyGeoffrey O Littlejohn, Eric F Morand
The New England Journal of Medicine|April 23, 2020
Anifrolumab in Systemic Lupus Erythematosus. ReplyEric F Morand, Richard A Furie
Trends in Molecular Medicine|July 10, 2025
10 years in lupus - progress, but not enoughEric F Morand, Sarah A Jones
Arthritis and Rheumatism|February 7, 2003
Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritisEric F Morand, Richard Bucala, Michelle Leech
Pageof 23